Intellectual Property India Publishes Patent Application for 'FCRN Antagonist Molecules And Methods Of Use Thereof' Filed by Argenx Bv

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517045527 A) filed by Argenx Bv, Ghent, Belgium, on May 12, for 'fcrn antagonist molecules and methods of use thereof.'

Inventor(s) include Stals Hilde; Meerschaert Kris; Hanssens Valerie; and Borgions Filip.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The disclosure provides populations of FcRn antagonist molecules mixtures of these populations and methods of using these populations to reduce the level of serum IgG autoantibodies in a subject."

The patent application was internationally filed on Nov. 14, 2023, under International application No.PCT/IB2023/000696.

Disclaimer: Curated by HT Syndication.